期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

FL与白血病

FL and leukemia
下载PDF
导出
摘要 FL(Flt3 ligand)为Flt3的配体,是一种与造血调控有关的造血细胞生长因子,其可能与白血病的发病有一定关系。已有体外实验证实将其作为树突状细胞(DC)的诱导剂,从而在肿瘤免疫治疗中开辟一个崭新的领域。本文将FL与白血病方面的关系作一综述。 FL（flt3 ligand）is an early acting hematopoietic cytokine.It is possible that FL has some relationship with leukemia.Recently,some studies has shown that FL can be applicated for tumor immunotherapy.This paper reviews the relationship between FL and leukemia.
作者 王静 化罗明 郭晓楠
机构地区 河北大学附属医院 河北医科大学附属第二医院
出处 《现代肿瘤医学》 CAS 2013年第6期1388-1390,共3页 Journal of Modern Oncology
关键词 FL 白血病 免疫治疗 FL leukemia tumor immunotherapy
分类号 R733.7 [医药卫生—肿瘤]
  • 相关文献

参考文献17

  • 1Chklovskaia E, Jansen W, Nissen C,et al. Mechanism of flt3 geneligand expression in bone marrow failure: translocation from intra-cellular stores to the surface of lymphocytes after chemotherapy in-duced suppression of hematopoiesis[ J]. Blood, 1999,93 (8) :2595-2604.
  • 2Drexler HG. Expression of Flt3 receptor and response to Flt3 ligandby leukemia cells[ J] . Leukemia, 1996,10(4) :588 -599.
  • 3Meierhoff G,Dehmel U,Gruss HJ,et al. Expression of the FLT3 re-ceptor and FLT3 ligand in human leukemia - lymphoma cell lines[J]. Leukemia,1996,9(8): 1368 - 1372.
  • 4Zheng R,Levis M,Piloto 0,et al. FLT3 ligand causes autocrine sig-naling in acute myeloid leukemia cells [ J ]. Blood, 2004,103 (1):267 -274.
  • 5Stacchini A,Fubini L,Severino A,et al. Expression of type HI re-ceptor tyrosine kinase FLT3 and KIT and response to their ligandsby acute myeloid leukemia blasts [ J ]. Leukemia, 1996,10 (10):1584-1591.
  • 6王静,韩颖,化罗明,郭晓楠,徐世荣.Flt3/FL在急性白血病中的表达及其临床意义[J].临床荟萃,2009,24(23):2073-2075. 被引量：2
  • 7王静,化罗明,郭晓楠,徐世荣,贾存荣.Flt3配体在急性髓系白血病化疗过程中的变化及意义[J].广东医学,2012,33(17):2639-2640. 被引量：6
  • 8曹仕煜,陈永锋.FL与骨髓造血调控[J].四川解剖学杂志,2009,17(3):41-42. 被引量：3
  • 9Maraskovsky E,Daro E,Roux E,et al. In vivo generation of humandendritic cells subsets by Flt3 ligand[ J]. Blood,2000,96(3) :878-884.
  • 10Mckenna HJ. Role of hematopoietic growth factors/flt3 ligand inexpansion and regulation of dendritic cells [ J ] . Curr Opin Hema-tol,2001,8(3) : 149 - 154.

二级参考文献39

  • 1Li K, Yang M, Lam AC,et al. Effects of flt-3 ligand in combination with TPO on the expansion of megakaryocytic progenitors, 2000,9(1) : 125-131.
  • 2Robinson S, Mosley RL, Parajuli P, et al. Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macropbage colony-stimulating factor acting alone or in combination. J Hematother Stem Cell Res,2000,9(5):711-720.
  • 3Blumenthal RD, Walter L, Malik J, et al. Plasma FLT3-L levels predict bone marrow recovery from myelosuppressive therapy. Cancer, 2000,88(2) :333-343.
  • 4Gazitt Y, Liu Q, High steady-state plasma levels of flt3-ligand in the peripheral blood is a good predictor for poor mobilization of CD34 + PBSC in patients undergoing high-dose chemotherapy and stem cell rescue. J Hematother Stem Cell Res, 2000,9 (2) : 285-293.
  • 5Lyman SD,James L, Bos TV, et al. Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: a proliferative factor for primitive hematopoietic cells. Cell,1993,75(6): 1157-1167.
  • 6Lyman SD,James L,Johnson L,et al. Cloning of the human homologue of the murine fit3 ligand: a growth factor for early hematopoietic progenitor cells. Blood, 1994,83(10) : 2795-2801.
  • 7Slanieka Krieger M, Nissen C, Manz CY, et al. The membranebound isoform of stem cell factor synergizes with soluble flt3 ligand in supporting early hematopoietie cells in long-term cultures of normal and aplastie anemia bone marrow. Exp Hematol, 1998,26 (5):365-373.
  • 8Drexler HG,Quentmeier H. FLT3; receptor and ligand. Growth Factors. 2004, 22(2) : 71-73.
  • 9Savvides SN, Boone T, Andrew Karplus P. Flt3 ligand structure and unexpected commonalities of helical bundles and cystine knots. Nat Struct Biol. 2000;7(6) :486-491.
  • 10Papayannopoulou T, Nakarnoto B, Andrews RG, et al. In vivo effects of Flt3/Flk2 ligand on mobilization of hernatopoietic progenitors in primates and potent synergistic enhancement with granulocyte colonystimulating factor. Blood, 1997,90(2):620-629.

共引文献6

现代肿瘤医学
2013年 第6期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部